Latest News

Heparin derivative suppresses neuroblastoma tumor growth

A new strategy for treating neuroblastoma using a modified version of heparin, a century-old injectable drug that thins the blood to prevent clots from forming, has been discovered by researchers. The study, conducted in mice, found that when heparin is altered to remove its blood-thinning properties, it can suppress and shrink neuroblastoma tumors without causing severe bleeding.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Major vascular anomalies found in brains of people with Huntington's disease

  • Genetic predisposition found for noise-induced hearing loss

  • Research Finds No Correlation between Regulatory T Cells and Survival in Glioblastoma

  • Smokers who use e-cigarettes less likely to quit, study shows

  • Adenosine receptor can activate 'off signals' for pain

  • Playing a wind instrument could help lower the risk of sleep apnea

  • Local physician recommends World Health Organization retire the term opioid substitution therapy

  • Cancer and chemobrain: Cancer diagnosis affects cognitive function

  • Forming school networks to educate 'the new mainstream'

  • Kids with ADHD must squirm to learn, study says

  •